TrianglePUBLICATIONS · 37058687
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jun 1
- First author
- Makker V
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Makker V
- type
- Author
- name
- Colombo N
- type
- Author
- name
- Casado Herráez A
- type
- Author
- name
- Monk BJ
- type
- Author
- name
- Mackay H
- type
- Author
- name
- Santin AD
- type
- Author
- name
- Miller DS
- type
- Author
- name
- Moore RG
- type
- Author
- name
- Baron-Hay S
- type
- Author
- name
- Ray-Coquard I
- type
- Author
- name
- Ushijima K
- type
- Author
- name
- Yonemori K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Makker V
- type
- Author
- name
- Colombo N
- type
- Author
- name
- Casado Herráez A
- type
- Author
- name
- Monk BJ
- type
- Author
- name
- Mackay H
- type
- Author
- name
- Santin AD
- type
- Author
- name
- Miller DS
- type
- Author
- name
- Moore RG
- type
- Author
- name
- Baron-Hay S
- type
- Author
- name
- Ray-Coquard I
- type
- Author
- name
- Ushijima K
- type
- Author
- name
- Yonemori K
- type
- Author
- bibliography ids
- nci-bib-3ce118f39eeb46509e0e65a7
- book metadata
- content sha256
- 84d50f370f707635d9f216ae888ef08b8994e869c492d8ab94dc55f7280e17f9
- document type
- citation
- dois
- 10.1200/JCO.22.02152
- electronic publication date
- display
- 2023 Apr 14
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37058687
- immutable id
- pubmed:37058687@84d50f370f707635d9f216ae888ef08b8994e869c492d8ab94dc55f7280e17f9
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 16
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2904-2910
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37058687
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- a2cc8729913f535a9ebdf599a1d1c02d4fff498d1c6f604df1a2964a72648a44
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Jun 1
- precision
- day
- year
- 2023
- publication types
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
Preserved source evidence · Not medical advice